Integra Lifesciences Sees Q2 Adj EPS $0.44-$0.52 vs $0.53 Est; Sees Sales $410.000M-$425.000M vs $425.403M Est

Benzinga Newsdesk www.benzinga.com Neutral 76.1%

Neg 0% Neu 76.1% Pos 0%

Integra Lifesciences (NASDAQ:IART) is looking for Q2 Adj EPS of $0.44-$0.52 vs $0.53 analyst estimate. sees sales of $410.000 million-$425.000 million vs $425.403 million analyst estimate.